Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3358 results

Sort By:

Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor

Study ID: NCT06572631
Start Date: 2025-06-07
End Date: 2026-12-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

31

Intervention / Treatment

Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Cyclophosphamide

Decitabine

Echocardiography

Fludarabine

Leukapheresis

Magnetic Resonance Imaging

Positron Emission Tomography

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Interaction Between Early Trauma and Odor-induced Dopamine Release

Study ID: NCT06284382
Start Date: 2025-06-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

High score at Childhood Trauma Questionnaire.

Low score at Childhood Trauma Questionnaire.

Sponsor

Le Vinatier Hospital

Source: clinicaltrials.gov

Share:
Add to list

Promoting Maintenance of Change Following Brief Intervention for Alcohol Use

Study ID: NCT05712382
Start Date: 2026-09
End Date: 2027-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Parent handbook

Coping with negative emotions

Problem-solving risky situations

Recovering from slips

Sponsor

University of Massachusetts, Amherst

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Anti-angiogenic Therapy with IV Bevacizumab in Patients with Symptomatic Cerebral Arteriovenous Malformations

Study ID: NCT06264531
Start Date: 2025-06
End Date: 2027-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

54

Intervention / Treatment

Infatuating

Placebo

Sponsor

Rothschild Adolphe Ophthalmological Foundation

Source: clinicaltrials.gov

Share:
Add to list

Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis

Study ID: NCT02720874
Start Date: 2025-06-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Rheumatoid arthritis educational booklet

Multidisciplinary rheumatologic care

Nurse education and monthly calls

Monthly healthcare coordinator calls

Technology-based symptom monitoring and reporting

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Optic Neuritis Using Synthetic Quantitative MRI

Study ID: NCT06916182
Start Date: 2025-06
End Date: 2027-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

MRI sequence

Sponsor

Rothschild Adolphe Ophthalmological Foundation

Source: clinicaltrials.gov

Share:
Add to list

Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy

Study ID: NCT06377982
Start Date: 2025-09
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

12

Intervention / Treatment

hUCB

Sponsor

StemCyte Taiwan Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Avatar Contraception Communication Training

Study ID: NCT05995574
Start Date: 2025-07-01
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

166

Intervention / Treatment

avatar communication training

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia

Study ID: NCT06547866
Start Date: 2025-06-01
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

zanubrutinib + BGB-11417

Sponsor

French Innovative Leukemia Organisation

Source: clinicaltrials.gov

Share:
Add to list

PH Sensitive MRI Based Resections of Glioblastoma

Study ID: NCT06176066
Start Date: 2025-07-01
End Date: 2029-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

CEST PH MRI based resection of glioblastoma

Sponsor

University of California, Los Angeles

Source: clinicaltrials.gov

Share:
Add to list